Volume 68, Issue suppl_1, May 2013
Evolution of antimicrobial resistance in Canadian hospitals from 2007 to 2011: results of the CANWARD study
Preface
Preface
Philip D. Lister and Alan P. Johnson
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Page i1, https://doi.org/10.1093/jac/dkt093
Articles
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11
Philippe R. S. Lagacé-Wiens and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i23–i29, https://doi.org/10.1093/jac/dkt023
Introduction to the CANWARD study (2007–11)
Daryl J. Hoban and George G. Zhanel
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i3–i5, https://doi.org/10.1093/jac/dkt021
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals
Ross J. Davidson and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i31–i37, https://doi.org/10.1093/jac/dkt024
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007–11) in bacterial pathogens isolated in Canadian hospitals
James A. Karlowsky and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i39–i46, https://doi.org/10.1093/jac/dkt025
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada
Kimberly A. Nichol and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i47–i55, https://doi.org/10.1093/jac/dkt026
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11
Andrew J. Denisuik and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i57–i65, https://doi.org/10.1093/jac/dkt027
Integrating pharmacokinetics, pharmacodynamics and MIC distributions to assess changing antimicrobial activity against clinical isolates of Pseudomonas aeruginosa causing infections in Canadian hospitals (CANWARD)
Sheryl A. Zelenitsky and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i67–i72, https://doi.org/10.1093/jac/dkt028
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study
George G. Zhanel and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_1, May 2013, Pages i7–i22, https://doi.org/10.1093/jac/dkt022
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals